These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32481364)

  • 21. Study protocol: fish oil supplement in prevention of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer patients - a randomized controlled trial. (OxaNeuro).
    Gehr NL; Karlsson P; Timm S; Christensen S; Hvid CA; Peric J; Hansen TF; Lauritzen L; Finnerup NB; Ventzel L
    BMC Cancer; 2024 Feb; 24(1):168. PubMed ID: 38308227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Huangqi Guizhi Wuwu Decoction Improves Inflammatory Factor Levels in Chemotherapy-induced Peripheral Neuropathy by Regulating the Arachidonic Acid Metabolic Pathway.
    Wang S; Du X; Yan G; Yang L; Sun H; Zhang X; Kong L; Han Y; Han D; Tang S; Wang X
    Curr Pharm Des; 2024; 30(34):2701-2717. PubMed ID: 39092641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect and safety of Huangqi-Guizhi-Wuwu Decoction and Erxian Decoction in the treatment of frozen shoulder: A protocol for systematic review and meta-analysis.
    Zhang YW; Jiang C; Li XH; Li K
    Medicine (Baltimore); 2020 Jun; 99(23):e20540. PubMed ID: 32502014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients.
    Cheng X; Huo J; Wang D; Cai X; Sun X; Lu W; Yang Y; Hu C; Wang X; Cao P
    Front Pharmacol; 2017; 8():344. PubMed ID: 28638341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herbal formula Huangqi Guizhi Wuwu decoction attenuates paclitaxel-related neurotoxicity via inhibition of inflammation and oxidative stress.
    Lv Z; Shen J; Gao X; Ruan Y; Ling J; Sun R; Dai J; Fan H; Cheng X; Cao P
    Chin Med; 2021 Aug; 16(1):76. PubMed ID: 34376246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Huangqi Guizhi Wuwu Decoction for treating cervical radiculopathy: A systematic review and meta-analysis of randomized controlled trials.
    Liang L; Wei X; Feng M; Zhu L; Yu J; Yang G; Yin X; Zhou S; Li K; Yang M; Wang X
    Medicine (Baltimore); 2020 Feb; 99(7):e19137. PubMed ID: 32049834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Traditional Chinese Medicine syndrome analysis on oxaliplatin-induced peripheral neuropathy and clinical efficacy of Bushen Yiqi formula: a prospective randomized controlled study.
    Longci P; Chunhui QI; Xubo S; Yixian H; Xinrong Y; Xianjun S
    J Tradit Chin Med; 2023 Oct; 43(6):1234-1242. PubMed ID: 37946486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Huangqi Guizhi Wuwu Decoction attenuates Podocyte cytoskeletal protein damage in IgA nephropathy rats by regulating AT1R/Nephrin/c-Abl pathway.
    Liu W; Shi L; Wan Q; Wu Y; Huang D; Ou J; Liu Q; Guan X; Yang Y; Zhang X; Gao J
    Biomed Pharmacother; 2021 Oct; 142():111907. PubMed ID: 34339916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Huangqi Guizhi Wuwu decoction improves hemorheology and inhibits inflammatory response after PCI for acute myocardial infarction.
    Dang M; Zhao X; Cao Y; Guan X; Liu Y
    Am J Transl Res; 2023; 15(5):3686-3696. PubMed ID: 37303648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic Analysis of Huangqi Guizhi Wuwu Decoction on Blood and Brain Tissue in Rats with Normal and Cerebral Ischemia-Reperfusion Injury by Microdialysis with HPLC-MS/MS.
    Zheng HZ; Shen X; He YY; Yan XL; Wang SX; Yu AM; Wang LS
    Drug Des Devel Ther; 2020; 14():2877-2888. PubMed ID: 32764886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Huangqi-Guizhi-Wuwu decoction regulates differentiation of CD4
    Xu N; Han X; Zhang X; Wang J; Yuan J; Wang M; Wu H; Huang F; Shi H; Yang L; Wu X
    Phytomedicine; 2024 Mar; 125():155239. PubMed ID: 38308917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial.
    Chan K; Lui L; Yu K; Lau K; Lai M; Lau W; Ng B; Zhong LLD; Bian ZX
    Trials; 2020 Jan; 21(1):58. PubMed ID: 31918748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Active Ingredients of Huangqi Guizhi Wuwu Decoction for Promoting Nerve Function Recovery After Ischemic Stroke Using HT22 Live-Cell-Based Affinity Chromatography Combined with HPLC-MS/MS.
    He Y; Zheng H; Zhong L; Zhong N; Wen G; Wang L; Zhang Y
    Drug Des Devel Ther; 2021; 15():5165-5178. PubMed ID: 35002223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of the chemotherapy-induced peripheral neuropathy integrated assessment - oxaliplatin subscale: a prospective cohort study.
    Gu Z; Chen C; Gu J; Song Z; Wei G; Cai G; Shu Q; Zhu L; Zhu W; Deng H; Li S; Chen A; Yin Y; Wu Q; Zhu H; Li G; Dai A; Huo J
    BMC Cancer; 2023 Nov; 23(1):1109. PubMed ID: 37964212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial.
    Balayssac D; Ferrier J; Pereira B; Gillet B; Pétorin C; Vein J; Libert F; Eschalier A; Pezet D
    BMJ Open; 2015 Apr; 5(4):e007479. PubMed ID: 25833669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial.
    Zhou L; Liu R; Huang D; Li H; Ning T; Zhang L; Ge S; Bai M; Wang X; Yang Y; Wang X; Chen X; Gao Z; Luo L; Yang Y; Wu X; Deng T; Ba Y
    EClinicalMedicine; 2021 Nov; 41():101157. PubMed ID: 34765950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Baihu and Guizhi decoction in acute gouty arthritis: study protocol for a randomized controlled trial.
    He Y; Dai C; Shen J; Chen Q; Gao J; Pan X; Gan J
    Trials; 2022 Apr; 23(1):317. PubMed ID: 35428324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the absorbed constituents and metabolites of Huangqi Guizhi Wuwu decoction by ultrahigh-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Fan Z; Li L; Cui Y; Tang X; Shen G; Feng B; Guan J; Zhu H
    Biomed Chromatogr; 2024 Feb; 38(2):e5783. PubMed ID: 38014563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Traditional Chinese medicine (Liang-Xue-Di-Huang Decoction) for hemorrhoid hemorrhage: Study Protocol Clinical Trial (SPIRIT Compliant).
    Shi SY; Zhou Q; He ZQ; Shen ZF; Zhang WX; Zhang D; Xu CB; Geng J; Wu BS; Chen YG
    Medicine (Baltimore); 2020 Apr; 99(16):e19720. PubMed ID: 32311960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Traditional Chinese medicine (Xiaoai Jiedu Decoction) as an adjuvant treatment for prevention new colorectal adenomatous polyp occurrence in post-polypectomy: Study protocol for a randomized controlled trial.
    Zhou Q; Chen YG; Xiao J; Chen TT; Liu JR; Zhou W; Li WZ; Wang Y; Zhang BP; Lin J; Meng FD; Gong B; Zheng GY; Han ST; Cheng HB
    Medicine (Baltimore); 2019 Aug; 98(31):e16680. PubMed ID: 31374049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.